US OptionsDetailed Quotes

BCTX241220C1000

Watchlist

0.05
+0.01+25.00%

15min DelayClose Dec 13 16:00 ET

0.05High0.05Low

BriaCell Therapeutics Stock Discussion

Jaguar8

Yesterday 08:10

🕛Watchlist MONDAY December 16. NFA. Trade the chart. Be kind… in progress

$Gorilla Technology (GRRR.US)$ PR: CEO will have interview with Red Chip Small Stock, Big Money show on Sat Dec 14. Reports on CEO on X that they have been selected from the shortlist for the $438M deal in SE Asia. Low float. $23.2M cash good for 12 months
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...

Trytosaveabit

Dec 13 06:55

Update

$BriaCell Therapeutics (BCTX.US)$ Briacell Therapeutics Highlights The Infiltration Of Cancer Fighting Immune Cells Into Tumors, Using CD8 ImmunoPET Imaging Technology, In Its Poster Presentation At 2024 San Antonio Breast Cancer Symposium
Benzinga· 1 min ago

Jaguar8

Dec 13 06:50

NEWS

$BriaCell Therapeutics (BCTX.US)$
BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer
Friday, 13th December at 7:50 am
BriaCell reports influx of cancer fighting CD8+ "killer" T cell into metastatic breast cancer tumors and lymph organs turning "Cold" tumors and lymph nodes "Hot" on ImmunoPET imaging in cancer patients treated with Bria-IMT™ plus an immune checkpoint inhibitor (CPI)
Imaging confirms clinical...

Willy 5150

Dec 12 10:06

I'm About To Scale Into This

$BriaCell Therapeutics (BCTX.US)$ Bearish news - Offering but no bad news about the company. Low risk, big reward potential imo. My SL below 0.50.

Stock_Drift

Dec 12 03:30

$BriaCell Therapeutics (BCTX.US)$

Trytosaveabit

Dec 11 15:07

Grrrr

$BriaCell Therapeutics (BCTX.US)$ Reuters· 2 mins ago
Briacell Therapeutics Announces Proposed Public Offering

Jaguar8

Dec 11 06:50

NEWS

$BriaCell Therapeutics (BCTX.US)$
BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®
Wednesday, 11th December at 7:50 am
Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months for those treated since 2022), double that of comparable patients in the literature
Final Phase 2 OS calculation is pending as many patients remain alive well over 1 year after starting...

JadeRuby

Dec 9 09:14

$BriaCell Therapeutics (BCTX.US)$ Pending good news leak out ?

carlton griffiths

Dec 3 21:23

$BriaCell Therapeutics (BCTX.US)$ 👀 hmm

Trytosaveabit

Dec 2 06:58

See if it actually gets volume! Good stuff! Update!

$BriaCell Therapeutics (BCTX.US)$ The Data Safety Monitoring Board Has Completed Its First Review Of Safety Events In Patients Enrolled In BriaCell Therapeutics' Phase 3 Study Of Bria-IMT Plus An Immune Checkpoint Inhibitor, Recommending Continuation Of The Study In Metastatic Breast Cancer Patients
The Data Safety Monitoring Board (DSMB) stated no safety concerns, and recommended continuation of BriaCell's pivotal Phase 3 study of Bria-IMT plus ...

No comment yet